TickerFacts.

Repligen Corp (RGEN): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$93.90M
Year ended 2025-12-31
$111.97M
Trailing 12 months to 2026-06-30
+2.5%
3-year compound annual growth
+18.5%
5-year compound annual growth
$149.72M2010-03-31: -$3.05M2011-03-31: $2.71M2012-12-31: $12.18M2013-12-31: $21.29M2016-12-31: $3.20M2017-12-31: $12.00M2018-12-31: $22.14M2019-12-31: $48.71M2020-12-31: $40.17M2021-12-31: $51.93M2022-12-31: $87.25M2023-12-31: $77.70M2024-12-31: $149.72M2025-12-31: $93.90M$93.90M
2010-03-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$93.90M-37.3%2026-02-26, From 2025-01-01
2024-12-31$149.72M+92.7%2026-02-26, From 2024-01-01
2023-12-31$77.70M-10.9%2026-02-26, From 2023-01-01
2022-12-31$87.25M+68.0%2025-03-14, From 2022-01-01
2021-12-31$51.93M+29.3%2024-11-18, From 2021-01-01
2020-12-31$40.17M-17.5%2023-02-22, From 2020-01-01
2019-12-31$48.71M+120.1%2022-02-17, From 2019-01-01
2018-12-31$22.14M+84.5%2021-02-24, From 2018-01-01
2017-12-31$12.00M+275.4%2020-02-26, From 2017-01-01
2016-12-31$3.20Mn/a2019-03-01, From 2016-01-01
No annual figure between 2013-12-31 and 2016-12-31.
2013-12-31$21.29M+74.9%2016-02-25, From 2013-01-01
2012-12-31$12.18Mn/a2015-03-17, From 2012-01-01
No annual figure between 2011-03-31 and 2012-12-31.
2011-03-31$2.71Mn/m2013-03-15, From 2010-04-01
2010-03-31-$3.05Mn/a2012-03-15, From 2009-04-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Repligen Corp (RGEN)2025-12-31$93.90M-37.3%
BioCryst Pharmaceuticals Inc (BCRX)2025-12-31$344.90Mn/m
ADMA Biologics, Inc. (ADMA)2025-12-31$27.82M-74.8%
Tarsus Pharmaceuticals, Inc. (TARS)2025-12-31-$22.31Mn/m
Bio-Techne Corp (TECH)2026-06-30$263.22M+2.6%
Immunocore Holdings plc (IMCR)2025-12-31-$15.05Mn/m
Halozyme Therapeutics, Inc. (HALO)2025-12-31$644.59M+37.6%
Krystal Biotech, Inc. (KRYS)2025-12-31$188.91M+58.5%
Twist Bioscience Corp (TWST)2025-09-30-$75.63Mn/m

Compare RGEN, BCRX, ADMA, TARS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗